BAMF Health

BAMF Health

Share

BAMF Health is achieving intelligence-based precision medicine through molecular imaging and molecular targeted radiation therapy.

Photos from BAMF Health's post 06/16/2026

FutureSolve is back! And this year it's bigger and better than ever.

The high school summer internship program is a collaboration between BAMF, Kent ISD, Ferris State University, and—new this year—Steelcase and Blox.

Our team has some exciting projects lined up for students, and their ideas have the potential to make a profound impact on our organization and patients.

Thank you to Andy McLean, Clay McNamara, Shelby Simon, Marissa Saenz, and Christine VanTimmeren for mentoring students this year!

Learn more: https://www.bamfhealth.com/news/futuresolve-student-intern-program-kicks-off-third-year-at-bamf/

06/09/2026

The man, the myth, the legend talks about the myths, the facts, and the impact of radiopharmaceutical clinical trials.

Our VP of Clinical Trials, Dan Rogers, joins The BAMF Health Podcast to talk about the role clinical trials play in advancing medicine, the complexities associated with radiopharmaceutical trials, and the challenges the industry faces.

Listen now: https://youtu.be/KC2xJQKwUDA

Lung Cancer Patient is First in the World to Participate in New Therapy Trial 06/04/2026

Angela has been battling lung cancer for six years, and now it’s metastatic. Chemotherapy helped a little, but the side effects were brutal and debilitating.

Her options were running out, so her doctor referred her to BAMF for a brand-new clinical trial. She’s now the first person in the world to participate in an innovative radiopharmaceutical therapy trial!

“I couldn’t get on the phone fast enough to come here. I wanted to get started right away.” - Angela

Learn more about her journey to BAMF and the Radiopharm Theranostics trial she’s participating in:

Lung Cancer Patient is First in the World to Participate in New Therapy Trial Angela is the first person in the world to participate in a new clinical trial exploring an investigational radiopharmaceutical therapy.

One in a million: West MI man with rare cancer joins clinical trial to help others 06/02/2026

He's one in a million.

At 16 years old, Sam (seen on the right) was diagnosed with a rare cancer that affects one in a million people. It's called epithelioid hemangioendothelioma, or EHE.

It's incredibly difficult to detect and even more complex to treat. But he's hoping his participation in a clinical trial at BAMF will help improve detection for others like him in the future.

Watch Sam's inspiring story: https://www.wzzm13.com/article/news/local/one-in-a-million-west-mi-man-with-rare-cancer-joins-clinical-trial-to-help-others/69-56f2848c-cef5-4ac2-bd83-03cf8ed7fc2d?utm_medium=social&utm_source=facebook_13_On_Your_Side&utm_id=97757_v0_s00_e0_tv2_a1demo0dynkuks&fbclid=IwY2xjawSKhUpleHRuA2FlbQIxMQBicmlkETFEUVZYdVE4T0RWRXJVeTRtc3J0YwZhcHBfaWQQMjIyMDM5MTc4ODIwMDg5MgABHk4jagNNQ-jxEuWUED6dwumrxqRZa2nwumu_FSg2IsmUbeVMA-1P-yy2SZ4D_aem_EQ5tZyOWmOc0pG-7EidQ3Q

One in a million: West MI man with rare cancer joins clinical trial to help others Sam Mulder has lived with a rare, untreatable cancer for seven years. Now, he's turning his pain into progress for future patients.

Want your practice to be the top-listed Clinic in Grand Rapids?
Click here to claim your Sponsored Listing.

Category

Address


109 Michigan Street NW, Suite 700
Grand Rapids, MI
49503

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm